申请人:Barrett Stephen D.
公开号:US20140031385A1
公开(公告)日:2014-01-30
The present invention provides for compounds of Formula I, and pharmaceutically acceptable salts thereof,
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, and R
7
have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as therapeutic agents in the treatment of TGFβ-mediated conditions, including cancer and fibrotic disorders. Also provided are pharmaceutical compositions comprising one or more compounds of Formula I.
本发明提供了式I的化合物及其药学上可接受的盐,其中R1、R2、R3、R4、R5、R6和R7的任何一个具有规范中定义的任何一个值,以及药学上可接受的盐,这些化合物在治疗TGFβ介导的疾病,包括癌症和纤维化疾病方面是有用的治疗剂。还提供了包含一个或多个式I化合物的制药组合物。